7 trends tracked about this subject — the full history, oldest to newest below.
New medical delivery methods known as brain-shuttle biologics are gaining attention following Denali's recent FDA approval for Alzheimer’s treatment.
Researchers and investors are evaluating new clinical data from Biogen as the firm explores tau-targeting treatments for Alzheimer’s disease.
A growing divide in the brain-computer interface market pits surgical implants against non-invasive wearable technology.
An AI biotech firm has acquired Novo's Parkinson's stem cell therapy following promising data from initial human trials.
6 news sources are covering this Business story right now — Newsylist is tracking how fast it spreads.
Novartis is expanding its cancer-drug pipeline through the acquisition of U.K.-based biotech firm Myricx Bio in a deal valued up to $1.5 billion.
The U.S. Department of Health and Human Services is launching a department-wide effort to accelerate clinical trials and restore American leadership in medical research.